Fig. 1
From: Cardiac device implantation and device usage in Fabry and hypertrophic cardiomyopathy
Survival free of any arrhythmic event, atrial fibrillation and ventricular arrhythmia requiring ATP/defibrillation therapy, in Fabry and hypertrophic cardiomyopathy. Event rates in Fabry and HCM. A Time to first arrhythmic event (p < 0.001). B Time to first episode of AF requiring anticoagulation (p = 0.001). C Time to first appropriate ATP/defibrillation therapy (p < 0.001)